"Missouri Cancer Associates is the premier cancer treatment facility in mid-Missouri. For over 30 years, our treatment center has remained faithful to keeping patient care at the root of what we do."

During the past decade, Missouri Cancer Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 27 clinical trials were completed, i.e. on average, 2700% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Missouri Cancer Associates" #1 sponsor was "US Oncology Research" with 10 trials, followed by "National Cancer Institute (NCI)" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "Eisai Inc." with 5 trials sponsored and "Celgene" with 5 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Missouri Cancer Associates" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Missouri Cancer Associates" are "Metastatic Breast Cancer" (8 trials), "Breast Cancer" (7 trials), "Prostate Cancer" (5 trials), "Advanced Breast Cancer" (3 trials) and "Small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "Missouri Cancer Associates" in a lesser frequency.

Most popular intervention types in "Missouri Cancer Associates" are "Drug" (57 trials), "Other" (9 trials), "Biological" (5 trials), "Radiation" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Laboratory Biomarker Analysis" (5 trials), "Prednisone" (4 trials), "cetuximab" (4 trials) and "docetaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Missouri Cancer Associates" are 41 trials for "All" genders, 12 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Missouri Cancer Associates". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Missouri Cancer Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Missouri Cancer Associates, 0 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".